YaoGeJu

Company directoryChina company filings

Shandong LINUO Pharmaceutical Co., Ltd

As of 20 November 2026, for the company name Shandong LINUO Pharmaceutical Co., Ltd as recorded, 2 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 21 records, across 13 drug names; since 23 August 2026, the records list Accepted: 2 applications (NMPA data as of 19 November 2026); the chemical-drug catalogue lists 15 active records with this name as holder.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/20
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/20.

Drug filings

21 acceptance records as first applicant, grouped into 13 source drug names. Source data as of 2026/11/20.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Dapagliflozin Tablets 2 records · Latest accepted 2026/11/11

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2602047Supplement2026/11/11Shandong LINUO Pharmaceutical Co., Ltd; Chongqing Bo Teng Pharma Co., Ltd. romanizedCDE ↗
CYHB2602046Supplement2026/11/11Shandong LINUO Pharmaceutical Co., Ltd; Chongqing Bo Teng Pharma Co., Ltd. romanizedCDE ↗
Betahistine Dihydrochloride Tablets 3 records · Latest accepted 2026/07/10

Supplement · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2601320Supplement2026/07/10Shandong LINUO Pharmaceutical Co., Ltd; Jinan Yong Ning Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHB2601319Supplement2026/07/10Shandong LINUO Pharmaceutical Co., Ltd; Jinan Yong Ning Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHB2601215Supplement2026/06/29Shandong LINUO Pharmaceutical Co., Ltd; Jinan Yong Ning Pharmaceutical Co., Ltd. romanizedCDE ↗
Febuxostat Tablets 2 records · Latest accepted 2025/09/24

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2501886Supplement2025/09/24Shandong LINUO Pharmaceutical Co., Ltd; Qingdao Bai Yang Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHB2501885Supplement2025/09/24Shandong LINUO Pharmaceutical Co., Ltd; Qingdao Bai Yang Pharmaceutical Co., Ltd. romanizedCDE ↗
Isavuconazonium Sulfate for Injection 1 records · Latest accepted 2025/03/18

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2500549Supplement2025/03/18Shandong LINUO Pharmaceutical Co., Ltd; Shanxi De Yuan Tang Pharma Co., Ltd. romanizedCDE ↗
Metformin Hydrochloride And Empagliflozin Extended Release Tablets 2 records · Latest accepted 2024/12/17

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2404373Generic2024/12/17Shandong LINUO Pharmaceutical Co., Ltd; Chongqing Bo Teng Pharma Co., Ltd. romanizedCDE ↗
CYHS2404372Generic2024/12/17Shandong LINUO Pharmaceutical Co., Ltd; Chongqing Bo Teng Pharma Co., Ltd. romanizedCDE ↗
Isosorbide Dinitrate Injection 2 records · Latest accepted 2024/10/24

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2403591Generic2024/10/24Shandong LINUO Pharmaceutical Co., Ltd; Zhongfu Pharmaceutical Co., Ltd.CDE ↗
CYHS2403590Generic2024/10/24Shandong LINUO Pharmaceutical Co., Ltd; Zhongfu Pharmaceutical Co., Ltd.CDE ↗
Esmolol Hydrochloride Injection 1 records · Latest accepted 2024/10/12

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2403395Generic2024/10/12Shandong LINUO Pharmaceutical Co., Ltd; Shandong Fang Ming Pharma Group Co., Ltd. romanizedCDE ↗
Piracetam Injection 2 records · Latest accepted 2024/10/10

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2403348Generic2024/10/10Shandong LINUO Pharmaceutical Co., Ltd; Shandong Fang Ming Pharma Group Co., Ltd. romanizedCDE ↗
CYHS2403347Generic2024/10/10Shandong LINUO Pharmaceutical Co., Ltd; Shandong Fang Ming Pharma Group Co., Ltd. romanizedCDE ↗
Lurasidone Hydrochloride Tablets 1 records · Latest accepted 2024/07/23

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2402309Generic2024/07/23Shandong LINUO Pharmaceutical Co., LtdCDE ↗
Calcium Dobesilate Capsules 1 records · Latest accepted 2024/05/15

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2400655Supplement2024/05/15Shandong LINUO Pharmaceutical Co., Ltd; Hainan Lin Heng Pharmaceutical Co., Ltd. romanizedCDE ↗
Piracetam Tablets 2 records · Latest accepted 2024/01/18

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450051Supplement2024/01/18Shandong LINUO Pharmaceutical Co., LtdCDE ↗
CYHB2450050Supplement2024/01/18Shandong LINUO Pharmaceutical Co., LtdCDE ↗
Metformin Hydrochloride Extended-release Tablets 1 records · Latest accepted 2023/10/21

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2302346Supplement2023/10/21Shandong LINUO Pharmaceutical Co., Ltd; Gai Tian Li Pharmaceuticals Holding Group Pharmaceutical Co., Ltd. romanizedCDE ↗
Isosorbide Mononitrate Extended-Release Tablets 1 records · Latest accepted 2021/10/26

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150940Supplement2021/10/26Shandong LINUO Pharmaceutical Co., LtdCDE ↗

Changes in the last 90 days

2 events from 2026/08/23 to 2026/11/20. CDE data as of 2026/11/20; NMPA data as of 2026/11/19.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Accepted: 2 applications

  1. 2026/11/11Accepted

    Dapagliflozin Tablets

    CYHB2602047

    Fact date: 2026/11/11 · Date added to this site: 2026/11/12

    View source ↗
  2. 2026/11/11Accepted

    Dapagliflozin Tablets

    CYHB2602046

    Fact date: 2026/11/11 · Date added to this site: 2026/11/12

    View source ↗

Under review

2 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/20.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Dapagliflozin Tablets CYHB2602047Supplement2026/11/11Shandong LINUO Pharmaceutical Co., Ltd; Chongqing Bo Teng Pharma Co., Ltd. romanizedCDE ↗
Dapagliflozin Tablets CYHB2602046Supplement2026/11/11Shandong LINUO Pharmaceutical Co., Ltd; Chongqing Bo Teng Pharma Co., Ltd. romanizedCDE ↗

Catalogue holder records

15 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/20. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerNMPA approval no.ApprovedCatalogue category (source text)View source
恩格列净二甲双胍缓释片(IV) · No verified English nameShandong LINUO Pharmaceutical Co., LtdChongqing Bo Teng Pharma Co., Ltd. romanized国药准字H202658442026/09/02Generic approved under the new chemical-drug registration classificationCDE ↗
恩格列净二甲双胍缓释片(III) · No verified English nameShandong LINUO Pharmaceutical Co., LtdChongqing Bo Teng Pharma Co., Ltd. romanized国药准字H202658432026/09/02Generic approved under the new chemical-drug registration classificationCDE ↗
Esmolol Hydrochloride InjectionShandong LINUO Pharmaceutical Co., LtdShandong Fang Ming Pharma Group Co., Ltd. romanized国药准字H202652792026/07/21Generic approved under the new chemical-drug registration classificationCDE ↗
Isosorbide Dinitrate InjectionShandong LINUO Pharmaceutical Co., LtdZhongfu Pharmaceutical Co., Ltd.国药准字H202652812026/07/21Generic approved under the new chemical-drug registration classificationCDE ↗
Isosorbide Dinitrate InjectionShandong LINUO Pharmaceutical Co., LtdZhongfu Pharmaceutical Co., Ltd.国药准字H202652802026/07/21Generic approved under the new chemical-drug registration classificationCDE ↗
Piracetam InjectionShandong LINUO Pharmaceutical Co., LtdShandong Fang Ming Pharma Group Co., Ltd. romanized国药准字H202640882026/04/21Generic approved under the new chemical-drug registration classificationCDE ↗
Piracetam InjectionShandong LINUO Pharmaceutical Co., LtdShandong Fang Ming Pharma Group Co., Ltd. romanized国药准字H202640872026/04/21Generic approved under the new chemical-drug registration classificationCDE ↗
Lurasidone Hydrochloride TabletsShandong LINUO Pharmaceutical Co., LtdShandong LINUO Pharmaceutical Co., Ltd国药准字H202631622026/01/20Generic approved under the new chemical-drug registration classificationCDE ↗
Isavuconazonium Sulfate for InjectionShandong LINUO Pharmaceutical Co., LtdShanxi De Yuan Tang Pharma Co., Ltd. romanized国药准字H202545372025/06/17Generic approved under the new chemical-drug registration classificationCDE ↗
Piracetam TabletsShandong LINUO Pharmaceutical Co., LtdShandong LINUO Pharmaceutical Co., Ltd国药准字H370235612024/11/19Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Piracetam TabletsShandong LINUO Pharmaceutical Co., LtdShandong LINUO Pharmaceutical Co., Ltd国药准字H370235612024/11/19Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Isosorbide Mononitrate Extended-Release TabletsShandong LINUO Pharmaceutical Co., LtdShandong LINUO Pharmaceutical Co., Ltd国药准字H199911152022/10/14Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Fluoxetine Hydrochloride Dispersible TabletsShandong LINUO Pharmaceutical Co., LtdShandong LINUO Pharmaceutical Co., Ltd国药准字H201231612021/12/07Drug that passed quality-and-efficacy consistency evaluationCDE ↗
IsosorbideMononitrate TabletsShandong LINUO Pharmaceutical Co., LtdShandong LINUO Pharmaceutical Co., Ltd国药准字H109402552021/10/27Drug that passed quality-and-efficacy consistency evaluationCDE ↗
IsosorbideMononitrate TabletsShandong LINUO Pharmaceutical Co., LtdShandong LINUO Pharmaceutical Co., Ltd国药准字H109401402021/10/27Drug that passed quality-and-efficacy consistency evaluationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

0 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/20.

NameCompany / applicantRegistration numberStatusSource update dateView source
No matching records were found in the currently loaded source data; coverage dates are listed below.

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/20.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
No matching records were found in the currently loaded source data; coverage dates are listed below.

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/20
Chemical-drug catalogue
Last successful update: 2026/11/20
API registrations
Last successful update: 2026/11/20
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.